A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

222

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Generalized Anxiety Disorder

Interventions

DRUG

PD 0332334

250 mg capsule, BID for 4 weeks

DRUG

PD 0332334

100 mg capsule, BID for 4 weeks

DRUG

placebo

0 mg capsule, BID for 4 weeks

DRUG

Alprazolam extended release

1 mg capsule, BID for 4 weeks